-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Sorrento Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Sorrento Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$77.2M, a 34.7% increase year-over-year.
- Sorrento Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$463M, a 4.85% decline year-over-year.
- Sorrento Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$504M, a 25.6% decline from 2021.
- Sorrento Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$401M, a 64.2% decline from 2020.
- Sorrento Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$245M, a 5.74% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)